Skip to main content

We are thrilled the Department of Statistics will remain a part of the Health Protection Research Unit in Emerging and Zoonotic Infections (HPRU EZI) team with the Pandemics Science Institute (PSI). The University of Liverpool, the host of the HPRU, has been award £5.5 million by the National Institute for Health Research (NIHR) to maintain the research unit. 

With the new iteration of the HPRU EZI due to the new award, means the continuation of the partnership between the University of Oxford, the University of Liverpool, and the UK Health Security Agency (UKHSA). The London School of Hygiene and Tropical Medicine (LSHTM) has recently joined the partnership, further enhancing the high-quality research carried out by the HPRU. 

Our department members, alongside the team from PSI, will continue active contribution to the research into emerging and zoonotic infections, i.e. infections which spread from animals to humans. The contributions include DPhil studentships, patient and public engagement and involvements (particularly those from marginalised communities), and work on non-pharmaceutical interventions (NPIs). 

Non-pharmaceutical interventions will be a focus going forward to provide a robust evidence base on the ethics and social acceptability of NPIs as well as their potential to safeguard public health. We are able to take an interdisciplinary approach by bringing together medical, behavioural and quantitative scientists.
Professor Christl Donnelly, Head of Department (Department of Statistics) and PSI Investigator

The Health Protection Research Unit (HPRU)

The HPRU in Emerging and Zoonotic Infections (EZI) was established in 2014 between the University of Oxford, the University of Liverpool, the Liverpool School of Tropical Medicine and the UKHSA. It is one of the units across the UK that help the UKHSA to carry out research of the highest quality to inform and support public health policies, practices, and services, so the UKHSA can protect us from emerging infections. 

To ensure the work provides highest value and the most impact, the HPRU EZI will collaborate extensively. This ambition is currently being realised through several new collaborations, two of which are major institutions: the Centre for Virus Research at the University of Glasgow, and The Pandemic Institute, Liverpool. 

The world has changed considerably since our unit was established in 2014, and especially since the start of the Covid-19 pandemic in 2020. The vision of our new unit is for the UK to be better prepared for emerging and zoonotic infections, especially of pandemic potential.
Professor Tom Solomon, Director of HPRU EZI

Safeguarding the Public

A total of 13 new HPRUs were announced recently by NIHR, as part of a £80 million research investment to keep the public safe from current and emerging public health threats. The HPRUs, which are all partnerships between top universities and UKHSA, will launch in April 2025 and run for five years.  

Related News

What does a statistician do for the England football team?

From squad selection to modelling how footballs behave at altitude, statistician Matt Penn explains how data is helping shape the modern game, and why coaches will always matter more than the numbers.

New evidence suggests vast hidden magma systems inside Mars

Researchers from the Departments of Earth Science and Statistics have found evidence that Mars once hosted enormous, Earth-like magmatic systems deep below its surface – even though the planet lacks the plate tectonics long considered essential for this kind of geological complexity. The findings open up new possibilities for how rocky planets become habitable.

Finding a needle in the genomic haystack: Targeting rare genes using statistical outliers

In statistical modelling, extreme outliers are often written off as 'noise'. But a new study by researchers from Oxford's Department of Statistics and Big Data Institute published this week in The American Journal of Human Genetics reverses that principle, using these outliers as the basis of a targeting system for locating rare, high-impact genetic mutations.